LEQEMBI shows high treatment persistence in real-world study

Go back to LEQEMBI shows high treatment persistence in real-world study
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 202.15 -0.8 (0.39%)
Previous Close $202.95    52 Week High $333.65 
Open $203.34    52 Week Low $223.02 
Day High $203.85    P/E 25.88 
Day Low $199.58    EPS $7.81 
Volume 227,507